Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vornov, J. J.
Right arrow Articles by Coyle, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vornov, J. J.
Right arrow Articles by Coyle, J. T.

Stroke, Vol 25, 457-464, Copyright © 1994 by American Heart Association


ARTICLES

Delayed protection by MK-801 and tetrodotoxin in a rat organotypic hippocampal culture model of ischemia

JJ Vornov, RC Tasker and JT Coyle
Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Md.

BACKGROUND AND PURPOSE: The hippocampus demonstrates a regional pattern of vulnerability to ischemic injury that depends on its characteristic differentiation and intrinsic connections. We now describe a model of ischemic injury using organotypic hippocampal culture, which preserves the anatomic differentiation of the hippocampus in long-term tissue culture. METHODS: Ischemic conditions were modeled by metabolic inhibition. Cultures were briefly exposed to potassium cyanide to block oxidative phosphorylation and 2-deoxyglucose to block glycolysis. The fluorescent dye propidium iodide was used to observe membrane damage in living cultures during recovery. RESULTS: 2-Deoxyglucose/potassium cyanide incubation resulted in dose-dependent, regionally selective neuronal injury in CA1 and the dentate hilus, which began slowly after 2 to 6 hours of recovery. Subsequent histological examination of cultures after 1 to 7 days of recovery demonstrated neuronal pyknosis that was correlated with the early, direct observation of membrane damage with propidium. Both propidium staining and histological degeneration were prevented by the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 when administered 30 minutes after the end of the exposure to 2-deoxyglucose and potassium cyanide. Tetrodotoxin, which blocks voltage-dependent sodium channels, had protective effects that were greatest during the period of 2- deoxyglucose and potassium cyanide incubation but also produced protection against the mildest conditions of metabolic inhibition when administered after 30 minutes of recovery. CONCLUSIONS: This in vitro model reproduced elements of the time course, regional vulnerability, and pharmacologic sensitivities of in vivo ischemic hippocampal injury. Inhibition of metabolism in organotypic culture provides a rapid, easily controlled injury and reproduces the in vitro pattern of hippocampal regional vulnerability to ischemia. It is the first in vitro model of ischemia to exhibit complete protection by delayed administration of an NMDA receptor antagonist during recovery from a brief insult. The protective effects of tetrodotoxin suggest that an early period of sodium entry into cells during and after ATP depletion may be responsible for the more prolonged period of toxic NMDA receptor activation.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. R. Elliott-Hunt, B. Marsh, A. Bacon, R. Pope, P. Vanderplank, and D. Wynick
Galanin acts as a neuroprotective factor to the hippocampus
PNAS, April 6, 2004; 101(14): 5105 - 5110.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. D. Winter, A. K Pringle, G. F. Clough, and M. K. Church
Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury
Brain, February 1, 2004; 127(2): 315 - 320.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. C. Barone, E. A. Irving, A. M. Ray, J. C. Lee, S. Kassis, S. Kumar, A. M. Badger, R. F. White, M. J. McVey, J. J. Legos, et al.
SB 239063, a Second-Generation p38 Mitogen-Activated Protein Kinase Inhibitor, Reduces Brain Injury and Neurological Deficits in Cerebral Focal Ischemia
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 312 - 321.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
K.-A. Hossmann
Experimental models for the investigation of brain ischemia
Cardiovasc Res, July 1, 1998; 39(1): 106 - 120.
[Full Text] [PDF]


Home page
NeuroscientistHome page
J. Hill Lucas, D. G. Emery, and L. J. Rosenberg
REVIEW {blacksquare} : Physical Injury of Neurons: Important Roles for Sodium and Chloride Ions
Neuroscientist, March 1, 1997; 3(2): 89 - 101.
[Abstract] [PDF]


Home page
StrokeHome page
A.K. Pringle, C.D. Benham, L. Sim, J. Kennedy, F. Iannotti, L.E. Sundstrom, and D. W. Choi
Selective N-Type Calcium Channel Antagonist Omega Conotoxin MVIIA Is Neuroprotective Against Hypoxic Neurodegeneration in Organotypic Hippocampal-Slice Cultures
Stroke, November 1, 1996; 27(11): 2124 - 2130.
[Abstract] [Full Text]